Here, we present a novel mechanism to indicate that lung adenocarcinoma progression mediated by the NKX2-1/p53 axis-modulated IKKβ expression is dependent on p53 status, particularly in wild-type Kras lung adenocarcinoma. The gene discussed is TP53; the disease is lung adenocarcinoma.